Domestic growth, launches in the US to aid pharma cos

Analysts expect healthy 10-11% growth for Indian pharma market during FY24.The demand rose across therapies, including acute therapies in December

Related Keywords

India ,Anand Rathi ,Zydus Lifescience ,Aurobindo Pharma ,Prabhudas Lilladher ,Analysts At Emkay Global Financial Services ,Cipla ,Indian Pharma Market ,Emkay Global Financial Services ,Capital Markets ,Indian Pharma Companies ,Zydus ,Growth ,